Janux Therapeutics, Inc.

JANX·NasdaqGM·Healthcare
Compare
18.18+0.36 (+2.02%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close17.82
Open18.19
Day range17.4418.33
52-week range12.1235.34
Off day high−0.82%
Off 52-week high−48.56%
Volume976.18K
Avg. volume (3M)834.64K
Market cap1.11B
EPS (TTM)-1.64
Forward P/E-6.93
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)2.39
Shares outstanding61.14M
Short interest11.15% of float
Earnings dateNov 5, 2026 (est.)
Analyst target33.81
Profit margin0.00%

Against its peers

Compare in full ›
JANX IMTX 8SJ.F CTMX BINV.ST IMCR
Market cap 1.11B 1.05B 1.84B 512.06M 252.69M 1.51B
P/E (TTM) — — — — — —
Forward P/E -6.9 -3.4 — -5.0 -1.0 -37.7
Price/book 1.2 2.1 2.4 1.7 1.3 3.6
Dividend yield — — — — — —
1-year change −36.57% −25.14% −37.59% −43.91% −88.73% −7.49%
Today +2.02% −2.33% +1.70% +7.80% +7.11% −2.66%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All JANX news ›

From the 4Search news index, newest first.

In the news

3mentions in 30 days
3with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance